Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genentech Ditches Stock Options to Fund $371 Million Retention Plan
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
Submitted by
admin
on August 22, 2008 - 10:02am
Source:
WSJ Online
Headline:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
Do Not Allow Advertisers to Use My Personal information
